Cover Image
Market Research Report

North America Intravascular Temperature Management Market Forecast 2019-2027

Published by Inkwood Research Product code 748432
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Intravascular Temperature Management Market Forecast 2019-2027
Published: November 22, 2018 Content info: 90 Pages
Description

KEY FINDINGS

The North American intravascular temperature management market is anticipated to rise with a CAGR of 2.52% during the forecast period 2019-2027 and has been valued at $xx million for the year 2018 and is expected to gain $xx million by the year 2027. This region is the dominant contributor to revenue for the global market and is majorly driven due to the easy availability of the devices required for intravascular temperature management.

MARKET INSIGHTS

The increasing statistics of minimally-invasive cosmetic procedures have increased nearly by XX% since 2000 in the United States is massively driving the intravascular temperature management market in the North American region. The United States market is the patron with the largest revenue is expected to speed up the market growth. Canada comprises the rapidly growing market for intravascular temperature management mainly due to the upsurging healthcare and surgeries expenditures due to favorable government healthcare policies.

The need for intravascular temperature management has increased in the scientific communities across the world, owing to the proper levels of awareness in developing economies, which is tagging along with the expectation of numerous market opportunities during the forecast period.

COMPETITIVE INSIGHTS

The key companies that are major competitors in the global market for intravascular temperature management are 3M Company, Asahi Kasei Corp., Becton, Dickinson, And Company, Belmont Instrument Corporation, Biegler GMBH, Estill Medical Technologies, Inc., Geratherm Medical AG, Inditherm PLC (Acquired By Inspiration Healthcare), Smiths Group PLC., Stihler Electronic GMBH, Stryker Corporation, The Surgical Company BV, The 37Company and Vyaire Medical Inc.

Table of Contents
Product Code: 22632

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CONSUMABLES PRODUCTS HOLDS THE LARGEST MARKET SHARE AND ARE ANTICIPATED TO GROW AT FASTER CAGR
    • 3.2.2. PREOPERATIVE CARE IS THE FASTEST GROWING APPLICATION DURING THE FORECAST PERIOD
    • 3.2.3. ACUTE MYOCARDIAL INFARCTION (AMI) INDICATION GENERATED THE HIGHEST REVENUE IN 2017
    • 3.2.4. AMBULATORY SURGICAL CENTERS ARE THE FASTEST GROWING END USER DURING THE FORECAST PERIOD

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASE IN NUMBER OF DIFFERENT SURGICAL PROCEDURES
    • 4.2.2. GROWING OCCURRENCE OF CARDIOVASCULAR DISEASE
    • 4.2.3. WIDE SCOPE OF INTRAVASCULAR TEMPERATURE MANAGEMENT APPLICATIONS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF SURGERIES
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. TECHNOLOGICAL ADVANCEMENTS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. STRINGENT REGULATION FOR APPROVAL OF DEVICES

5. MARKET BY PRODUCT

  • 5.1. SYSTEM
  • 5.2. CONSUMABLES

6. MARKET BY APPLICATION

  • 6.1. PREOPERATIVE CARE
  • 6.2. OPERATIVE CARE
  • 6.3. POST-OPERATIVE CARE
  • 6.4. ACUTE/CRITICAL CARE

7. MARKET BY INDICATION

  • 7.1. ACUTE MYOCARDIAL INFARCTION (AMI)
  • 7.2. STROKE
  • 7.3. CARDIAC ARREST
  • 7.4. FEVER/INFECTION
  • 7.5. OTHER INDICATION

8. MARKET BY END USER

  • 8.1. SURGICAL CENTERS
  • 8.2. EMERGENCY CARE UNITS
  • 8.3. AMBULATORY SURGICAL CENTERS
  • 8.4. OTHER END USER

9. KEY ANALYTICS

    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF SUPPLIERS
    • 9.1.4. BARGAINING POWER OF BUYERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. OPPORTUNITY MATRIX
  • 9.3. VENDOR LANDSCAPE

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. THE UNITED STATES
    • 10.1.2. CANADA

11. COMPETITIVE LANDSCAPE

  • 11.1. MARKET POSITION ANALYSIS
  • 11.2. COMPANY PROFILES
    • 11.2.1. 3M COMPANY
      • 11.2.1.1. COMPANY OVERVIEW
      • 11.2.1.2. PRODUCT PORTFOLIO
      • 11.2.1.3. SCOT ANALYSIS
      • 11.2.1.4. STRATEGIC INITIATIVES
    • 11.2.2. ASAHI KASEI CORP.
      • 11.2.2.1. COMPANY OVERVIEW
      • 11.2.2.2. PRODUCT PORTFOLIO
      • 11.2.2.3. SCOT ANALYSIS
      • 11.2.2.4. STRATEGIC INITIATIVES
    • 11.2.3. BECTON, DICKINSON, AND COMPANY
      • 11.2.3.1. COMPANY OVERVIEW
      • 11.2.3.2. PRODUCT PORTFOLIO
      • 11.2.3.3. SCOT ANALYSIS
      • 11.2.3.4. STRATEGIC INITIATIVES
    • 11.2.4. BELMONT INSTRUMENT CORPORATION.
      • 11.2.4.1. COMPANY OVERVIEW
      • 11.2.4.2. PRODUCT PORTFOLIO
      • 11.2.4.3. STRATEGIC INITIATIVES
    • 11.2.5. BIEGLER GMBH
      • 11.2.5.1. COMPANY OVERVIEW
      • 11.2.5.2. PRODUCT PORTFOLIO
    • 11.2.6. ESTILL MEDICAL TECHNOLOGIES, INC.
      • 11.2.6.1. COMPANY OVERVIEW
      • 11.2.6.2. PRODUCT PORTFOLIO
    • 11.2.7. GERATHERM MEDICAL AG
      • 11.2.7.1. COMPANY OVERVIEW
      • 11.2.7.2. PRODUCT PORTFOLIO
    • 11.2.8. INDITHERM PLC (ACQUIRED BY INSPIRATION HEALTHCARE)
      • 11.2.8.1. COMPANY OVERVIEW
      • 11.2.8.2. PRODUCT PORTFOLIO
    • 11.2.9. SMITHS GROUP PLC.
      • 11.2.9.1. COMPANY OVERVIEW
      • 11.2.9.2. PRODUCT PORTFOLIO
      • 11.2.9.3. SCOT ANALYSIS
      • 11.2.9.4. STRATEGIC INITIATIVES
    • 11.2.10. STIHLER ELECTRONIC GMBH
      • 11.2.10.1. COMPANY OVERVIEW
      • 11.2.10.2. PRODUCT PORTFOLIO
    • 11.2.11. STRYKER CORPORATION
      • 11.2.11.1. COMPANY OVERVIEW
      • 11.2.11.2. PRODUCT PORTFOLIO
      • 11.2.11.3. SCOT ANALYSIS
      • 11.2.11.4. STRATEGIC INITIATIVES
    • 11.2.12. THE SURGICAL COMPANY BV
      • 11.2.12.1. COMPANY OVERVIEW
      • 11.2.12.2. PRODUCT PORTFOLIO
      • 11.2.12.3. STRATEGIC INITIATIVES
    • 11.2.13. THE 37COMPANY
      • 11.2.13.1. COMPANY OVERVIEW
      • 11.2.13.2. PRODUCT PORTFOLIO
      • 11.2.13.3. STRATEGIC INITIATIVES
    • 11.2.14. VYAIRE MEDICAL INC.
      • 11.2.14.1. COMPANY OVERVIEW
      • 11.2.14.2. PRODUCT PORTFOLIO
      • 11.2.14.3. STRATEGIC INITIATIVES

LIST OF TABLES

  • TABLE 1 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET 2019-2027 ($ MILLION)
  • TABLE 2 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • TABLE 3 NORTH AMERICA SYSTEM MARKET 2019-2027 ($ MILLION)
  • TABLE 4 NORTH AMERICA CONSUMABLES MARKET 2019-2027 ($ MILLION)
  • TABLE 5 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 6 NORTH AMERICA PREOPERATIVE CARE MARKET 2019-2027 ($ MILLION)
  • TABLE 7 NORTH AMERICA OPERATIVE CARE MARKET 2019-2027 ($ MILLION)
  • TABLE 8 NORTH AMERICA POST-OPERATIVE CARE MARKET 2019-2027 ($ MILLION)
  • TABLE 9 NORTH AMERICA ACUTE/CRITICAL CARE MARKET 2019-2027 ($ MILLION)
  • TABLE 10 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY INDICATION 2019-2027 ($ MILLION)
  • TABLE 11 NORTH AMERICA ACUTE MYOCARDIAL INFARCTION (AMI) MARKET 2019-2027 ($ MILLION)
  • TABLE 12 NORTH AMERICA STROKE MARKET 2019-2027 ($ MILLION)
  • TABLE 13 NORTH AMERICA CARDIAC ARREST MARKET 2019-2027 ($ MILLION)
  • TABLE 14 NORTH AMERICA FEVER/INFECTION MARKET 2019-2027 ($ MILLION)
  • TABLE 15 NORTH AMERICA OTHER INDICATION MARKET 2019-2027 ($ MILLION)
  • TABLE 16 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 17 NORTH AMERICA SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
  • TABLE 18 NORTH AMERICA EMERGENCY CARE UNITS MARKET 2019-2027 ($ MILLION)
  • TABLE 19 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
  • TABLE 20 NORTH AMERICA OTHER END USER MARKET 2019-2027 ($ MILLION)
  • TABLE 21 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 22 THE UNITED STATES INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • TABLE 23 THE UNITED STATES INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 24 THE UNITED STATES INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY INDICATION 2019-2027 ($ MILLION)
  • TABLE 25 THE UNITED STATES INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 26 CANADA INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • TABLE 27 CANADA INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 28 CANADA INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY INDICATION 2019-2027 ($ MILLION)
  • TABLE 29 CANADA INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 30 INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM COMPANY MARKET POSITION 2017

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET SHARE BY PRODUCT 2017 & 2027 (%)
  • FIGURE 3 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY SYSTEM 2019-2027 ($ MILLION)
  • FIGURE 4 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY CONSUMABLES 2019-2027 ($ MILLION)
  • FIGURE 5 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET SHARE BY APPLICATION 2017 & 2027 (%)
  • FIGURE 6 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY PREOPERATIVE CARE 2019-2027 ($ MILLION)
  • FIGURE 7 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY OPERATIVE CARE 2019-2027 ($ MILLION)
  • FIGURE 8 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY POST-OPERATIVE CARE 2019-2027 ($ MILLION)
  • FIGURE 9 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY ACUTE/CRITICAL CARE 2019-2027 ($ MILLION)
  • FIGURE 10 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET SHARE BY INDICATION 2017 & 2027 (%)
  • FIGURE 11 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY ACUTE MYOCARDIAL INFARCTION (AMI) 2019-2027 ($ MILLION)
  • FIGURE 12 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY STROKE 2019-2027 ($ MILLION)
  • FIGURE 13 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY CARDIAC ARREST 2019-2027 ($ MILLION)
  • FIGURE 14 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY FEVER/INFECTION 2019-2027 ($ MILLION)
  • FIGURE 15 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY OTHER INDICATION 2019-2027 ($ MILLION)
  • FIGURE 16 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET SHARE BY END USER 2017 & 2027 (%)
  • FIGURE 17 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 18 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY EMERGENCY CARE UNITS 2019-2027 ($ MILLION)
  • FIGURE 19 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 20 NORTH AMERICA INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET BY OTHER END USER 2019-2027 ($ MILLION)
  • FIGURE 21 PORTER'S FIVE FORCE MODEL
  • FIGURE 22 THE UNITED STATES INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 23 CANADA INTRAVASCULAR TEMPERATURE MANAGEMENT SYSTEM MARKET 2019-2027 ($ MILLION)
Back to Top